Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases
Authors
Keywords
-
Journal
Neurotherapeutics
Volume 14, Issue 1, Pages 135-147
Publisher
Springer Nature
Online
2016-10-18
DOI
10.1007/s13311-016-0486-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
- (2016) Michael D. Lovelace et al. Frontiers in Immunology
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
- (2015) Ester Cantó et al. BRAIN
- Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs
- (2015) Ebrima Gibbs et al. CLINICAL IMMUNOLOGY
- Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection
- (2015) E. M. Mowry et al. EUROPEAN JOURNAL OF NEUROLOGY
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- PML risk stratification using anti-JCV antibody index and L-selectin
- (2015) Nicholas Schwab et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients
- (2015) Linda A. Lieberman et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- PML risk stratification using anti-JCV antibody index and L-selectin
- (2015) Nicholas Schwab et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
- (2015) Roberta Mancuso et al. PLoS One
- Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
- (2015) Marta Tejera-Alhambra et al. PLoS One
- Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome
- (2015) Karin Kannel et al. PLoS One
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β
- (2014) Bruna De Felice et al. BMC Medical Genomics
- Biobanking of CSF: International standardization to optimize biomarker development
- (2014) Charlotte E. Teunissen et al. CLINICAL BIOCHEMISTRY
- MicroRNA-15b promotes neurogenesis and inhibits neural progenitor proliferation by directly repressing TET3 during early neocortical development
- (2014) X. Lv et al. EMBO REPORTS
- Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
- (2014) Itay Raphael et al. Expert Review of Clinical Immunology
- Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity—Preliminary Study
- (2014) Magdalena Justyna Kacperska et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system
- (2014) Masami Tanaka et al. JOURNAL OF NEUROIMMUNOLOGY
- N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
- (2014) Alessandro Trentini et al. JOURNAL OF NEUROLOGY
- Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
- (2014) J. Kuhle et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
- (2014) Adipong Brickshawana et al. LANCET NEUROLOGY
- Increased anti-KIR4.1 antibodies in multiple sclerosis: Could it be a marker of disease relapse?
- (2014) Livnat Brill et al. Multiple Sclerosis Journal
- Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis
- (2014) Elodie Nerrant et al. Multiple Sclerosis Journal
- Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease
- (2014) Romana Höftberger et al. Multiple Sclerosis Journal
- Biomarker Studies in Multiple Sclerosis: From Proteins to Noncoding RNAs
- (2014) Xiao-Fang Liu et al. NEUROCHEMICAL RESEARCH
- Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease
- (2014) V. Kraus et al. NEUROLOGY
- Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders
- (2014) S. Gnanapavan et al. NEUROLOGY
- Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
- (2014) F. J. Quintana et al. NEUROLOGY
- Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
- (2014) Alberto Ascherio et al. JAMA Neurology
- Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
- (2013) Roopali Gandhi et al. ANNALS OF NEUROLOGY
- MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
- (2013) Michael Hecker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis
- (2013) C van de Kraats et al. Multiple Sclerosis Journal
- Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing
- (2013) Andreas Keller et al. Multiple Sclerosis Journal
- Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
- (2013) H Hegen et al. Multiple Sclerosis Journal
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
- (2013) Charlotte Teunissen et al. Multiple Sclerosis Journal
- Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
- (2013) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis
- (2013) Chiara Fenoglio et al. Multiple Sclerosis Journal
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis
- (2013) Hans-Peter Hartung et al. JAMA Neurology
- NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223
- (2012) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Circulating microRNAs involved in multiple sclerosis
- (2012) Sue Rutherford Siegel et al. MOLECULAR BIOLOGY REPORTS
- Disease Biomarkers in Multiple Sclerosis
- (2012) Violaine K. Harris et al. Molecular Diagnosis & Therapy
- CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
- (2012) M Khalil et al. Multiple Sclerosis Journal
- Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis
- (2012) Anke Vennegoor et al. Multiple Sclerosis Journal
- Characterization of anti-natalizumab antibodies in multiple sclerosis patients
- (2012) M Lundkvist et al. Multiple Sclerosis Journal
- Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
- (2012) J. Kitley et al. NEUROLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity
- (2012) L. Ottoboni et al. Science Translational Medicine
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Influence of the HLA-DRB1 Genotype on Antibody Development to Interferon Beta in Multiple Sclerosis
- (2011) Dorothea Buck et al. ARCHIVES OF NEUROLOGY
- A clear look at the neuroimmunology of multiple sclerosis and beyond
- (2011) Carlo Selmi et al. AUTOIMMUNITY REVIEWS
- Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study
- (2011) Sanna Hagman et al. JOURNAL OF NEUROIMMUNOLOGY
- Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
- (2011) Bianca Weinstock-Guttman et al. Journal of Neuroinflammation
- Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
- (2011) Samia Ragheb et al. Multiple Sclerosis Journal
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
- (2010) Chris H Polman et al. LANCET NEUROLOGY
- Neurofilament light as a prognostic marker in multiple sclerosis
- (2010) Jonatan Salzer et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood
- (2010) Mathew B. Cox et al. PLoS One
- Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models
- (2009) Hans Lassmann EXPERIMENTAL NEUROLOGY
- Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
- (2009) Amer Awad et al. JOURNAL OF NEUROIMMUNOLOGY
- Serum levels of CXCL13 are elevated in active multiple sclerosis
- (2009) Eugene D Festa et al. Multiple Sclerosis Journal
- Cerebrospinal fluid biomarkers in multiple sclerosis
- (2009) Hayrettin Tumani et al. NEUROBIOLOGY OF DISEASE
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Multiple sclerosis immunology: The healthy immune system vs the MS immune system
- (2009) L. H. Kasper et al. NEUROLOGY
- Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse
- (2009) Elizabeth Regina Comini Frota et al. NEUROSCIENCE LETTERS
- HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
- (2008) Steve Hoffmann et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Lessons from multiple sclerosis: models, concepts, observations
- (2008) H Wekerle ANNALS OF THE RHEUMATIC DISEASES
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- Interleukin-17 in transverse myelitis and multiple sclerosis
- (2008) J GRABER et al. JOURNAL OF NEUROIMMUNOLOGY
- Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
- (2008) F. J. Quintana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurotrophic cross-talk between the nervous and immune systems: Relevance for repair strategies in multiple sclerosis?
- (2007) Reinhard Hohlfeld JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis
- (2007) K. Rejdak et al. Multiple Sclerosis Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More